ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,394Medicare Part D Prescriptions Filled, Including Refills

Rank: 347 out of 2061

$583K Total Retail Price of All Prescriptions

Rank: 517 out of 2061

386 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 386 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 386 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 10,266 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
FUROSEMIDE 468 457 1 6
WARFARIN SODIUM 421 337 2 11
LISINOPRIL 417 376 3 2
LEVOTHYROXINE SODIUM 412 389 4 3
SIMVASTATIN 390 352 5 1
HYDROCODONE-ACETAMINOPHEN 334 308 S3 6 10
OMEPRAZOLE 303 252 7 5
CITALOPRAM HBR 288 259 8 20
METOPROLOL TARTRATE 238 228 9 7
GABAPENTIN 226 211 10 15
DIVALPROEX SODIUM 211 163 11 74
DONEPEZIL HCL 202 202 12 24
METFORMIN HCL 197 184 13 9
MIRTAZAPINE 187 174 14 46
AMLODIPINE BESYLATE 186 173 15 4
SERTRALINE HCL 172 159 16 21
TRAMADOL HCL 156 151 17 18
POTASSIUM CHLORIDE 151 151 18 16
DIOVAN 135 121 19 41
NAMENDA 134 132 20 37
RISPERIDONE 105 91 21 66
CARVEDILOL 101 94 22 22
HYDROCHLOROTHIAZIDE 96 90 23 12
ATORVASTATIN CALCIUM 92 85 24 8
AZITHROMYCIN 87 82 25 34
KLOR-CON M20 84 62 26 47
CYMBALTA 83 71 27 59
FAMOTIDINE 82 82 28 67
NOVOLOG 79 75 29 102
ATENOLOL 78 74 30 13
LANTUS 77 77 31 48
TAMSULOSIN HCL 76 57 32 30
POLYETHYLENE GLYCOL 3350 68 51 33 64
ZOLPIDEM TARTRATE 67 62 34 23
EXELON 67 67 34 94
METOPROLOL SUCCINATE 66 56 36 19
ALENDRONATE SODIUM 64 52 37 25
QUETIAPINE FUMARATE 64 56 37 72
LYRICA 64 46 37 83
ISOSORBIDE MONONITRATE ER 64 63 37 42
CARBIDOPA-LEVODOPA 62 62 41 97
OXYCODONE-ACETAMINOPHEN 62 19 S2 41 36
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 59 41 87
PREDNISONE 61 45 44 32
TRIAMTERENE-HCTZ 59 42 45 38
PAROXETINE HCL 58 52 46 61
PRIMIDONE 58 58 46 255
NOVOLIN R 58 58 46 129
CRESTOR 57 54 49 31
DIOVAN HCT 56 56 50 99
LACTULOSE 55 54 51 131
TRICOR 52 40 52 128
NEXIUM 51 41 53 26
LOVASTATIN 51 51 53 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.